↓ Skip to main content

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy

Overview of attention for article published in BMC Neurology, May 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
27 Mendeley